amantadine has been researched along with Brain Damage, Chronic in 3 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Preliminary, uncontrolled research has suggested possible benefit with amantadine for this behavioural syndrome." | 9.08 | N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. ( Bayley, M; Burke, IM; Fawcett, S; Garner, S; Hart, A; Thompson, W; Van Reekum, R, 1995) |
| " Preliminary, uncontrolled research has suggested possible benefit with amantadine for this behavioural syndrome." | 5.08 | N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. ( Bayley, M; Burke, IM; Fawcett, S; Garner, S; Hart, A; Thompson, W; Van Reekum, R, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Reekum, R | 1 |
| Bayley, M | 1 |
| Garner, S | 1 |
| Burke, IM | 1 |
| Fawcett, S | 1 |
| Hart, A | 1 |
| Thompson, W | 1 |
| Edby, K | 1 |
| Larsson, J | 1 |
| Eek, M | 1 |
| von Wendt, L | 1 |
| Ostergård, B | 1 |
| Hinkle, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)[NCT00127114] | Phase 4 | 0 participants (Actual) | Interventional | 2005-09-30 | Withdrawn (stopped due to No funding and exclusion criteria were to stringent.) | ||
| Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability: A Randomized, Double-Blind, Placebo-Controlled Trial[NCT00627250] | 76 participants (Actual) | Interventional | 2003-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for amantadine and Brain Damage, Chronic
| Article | Year |
|---|---|
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury.
Topics: Adult; Amantadine; Brain Damage, Chronic; Combined Modality Therapy; Dose-Response Relationship, Dru | 1995 |
2 other studies available for amantadine and Brain Damage, Chronic
| Article | Year |
|---|---|
Amantadine treatment of a patient with anoxic brain injury.
Topics: Activities of Daily Living; Adolescent; Amantadine; Antiparkinson Agents; Brain Damage, Chronic; Bra | 1995 |
Amantadine hydrochloride.
Topics: Amantadine; Brain Damage, Chronic; Brain Injuries; Humans; Neuropsychological Tests | 1991 |